Managing Healthcare Reform through Effective Public Policy & Government Affairs Strategies
CHAPEL HILL, N.C., Feb. 7, 2014 /PRNewswire/ -- As the healthcare landscape in the United States continues to change, organizations must interact with a wider range of federal agencies and state entities that will greatly affect healthcare policy. In order to properly address the needs of these agencies, organizations are increasingly looking to their Government Affairs, Public Policy and Managed Markets groups. Consequently, understanding how to structure, staff, and collaborate to navigate these dramatic changes is critical.
Along with the structure and staffing levels of Government Affairs and Public Policy groups, formal strategies put in place also play a large role in how effective companies are at guiding their organization through the government ecosystem. According to research by benchmarking firm, Best Practices, LLC, companies in the Large Pharma Segment of the study were more than twice as likely as the Mid-cap organizations to have formal strategies in place to engage the Federal Government across multiple agencies.
The research report, "Managing Healthcare Reform: Winning Strategies for Engaging the Government Ecosystem That Shapes Healthcare Policy," illuminates winning strategies for navigating healthcare reform. The research also identifies how companies in the healthcare industry can utilize their resources to cover and engage the various agencies and entities involved with public healthcare.
Key objectives addressed in this study include:
- Highlight the resources and functions that are most effective for engaging CMS and other groups that influence federal healthcare policy, guidelines and reimbursement.
- Identify effective organizational structure of Government Affairs and Public Policy and roles for managing public sector healthcare agencies and entities.
- Ascertain effective approaches for converting information from government healthcare sector into strategies, plans and tactics that will best position and protect commercial organization.
This study engaged executives from 23 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Eight participants formed the Large Pharma Segment as well as the Mid-Cap Segment. The Emerging Pharma Segment consists of seven companies. In addition, deep-dive interviews were conducted with six participating companies to gather additional insights.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1267.htm.
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC